Items where authors include "Everett, CC"

Article

Everett, CC, Berry, C, McCann, GP et al. (14 more authors) (2023) Randomised trial of stable chest pain investigation : 3-year clinical and quality of life results from CE-MARC 2. Open Heart. e002221. ISSN 2053-3624

Phillips, R, Cro, S, Wheeler, G et al. (22 more authors) (2022) Visualising harms in publications of randomised controlled trials: consensus and recommendations. BMJ, 377. e068983. ISSN 1759-2151

Berger, VW, Bour, LJ, Carter, K et al. (11 more authors) (2021) A roadmap to using randomization in clinical trials. BMC Medical Research Methodology, 21. 168. ISSN 1471-2288

Walker, Simon Mark orcid.org/0000-0002-5750-3691, Cox, Edward Miles, Rothwell, Ben et al. (13 more authors) (2020) Cost-effectiveness of Cardiovascular Imaging for Stable Coronary Heart Disease. Heart. ISSN 1468-201X

Everett, CC orcid.org/0000-0002-9788-840X, Fox, KAA, Reynolds, C et al. (10 more authors) (2019) Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial. BMJ Open, 9 (9). ARTN: 032165. ISSN 2044-6055

Nashef, SAM, Fynn, S, Abu-Omar, Y et al. (11 more authors) (2018) Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation. European Journal of Cardio-thoracic Surgery, 54 (4). pp. 729-737. ISSN 1010-7940

Brown, S orcid.org/0000-0002-1840-3786, Everett, CC orcid.org/0000-0002-9788-840X, Naraghi, K et al. (8 more authors) (2018) Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health Technology Assessment, 22 (34). ISSN 1366-5278

Fisher, BA, Everett, CC orcid.org/0000-0002-9788-840X, Rout, J et al. (24 more authors) (2018) Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the Rheumatic Diseases, 77 (3). pp. 412-416. ISSN 0003-4967

Zhao, W, Everett, CC orcid.org/0000-0002-9788-840X, Weng, Y et al. (1 more author) (2017) Guessing strategies for treatment prediction under restricted randomization with unequal allocation. Contemporary Clinical Trials, 59. pp. 118-120. ISSN 1551-7144

Bowman, SJ, Everett, CC orcid.org/0000-0002-9788-840X, O'Dwyer, JL orcid.org/0000-0002-7212-6089 et al. (21 more authors) (2017) Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. Arthritis & Rheumatology, 69 (7). pp. 1440-1450. ISSN 2326-5191

Greenwood, JP, Ripley, DP, Berry, C et al. (14 more authors) (2016) Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates : The CE-MARC 2 Randomized Clinical Trial. JAMA. pp. 1051-1060. ISSN 1538-3598

Greenwood, JP, Ripley, DP, Berry, C et al. (14 more authors) (2016) Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. Journal of the American Medical Association, 316 (10). pp. 1051-1060. ISSN 0098-7484

Greenwood, JP orcid.org/0000-0002-2861-0914, Herzog, BA, Brown, JM orcid.org/0000-0002-2719-7064 et al. (8 more authors) (2016) Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: Long-term follow-up of a prospective, diagnostic accuracy cohort study. Annals of Internal Medicine, 165 (1). pp. 1-9. ISSN 0003-4819

Ripley, DP, Motwani, M, Brown, JM et al. (6 more authors) (2015) Individual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trial. Journal of Cardiovascular Magnetic Resonance, 17. 59. ISSN 1097-6647

Coy, NCN, Brown, S, Bosworth, A et al. (15 more authors) (2014) The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug. BMC Musculoskeletal Disorders, 15. 452. ISSN 1471-2474

Proceedings Paper

Foley, JRJ orcid.org/0000-0003-0073-1025, Everett, CC orcid.org/0000-0002-9788-840X, Cairns, D orcid.org/0000-0002-2338-0179 et al. (6 more authors) (2017) Development and external validation of a multivariable model of pre-test likelihood of coronary artery disease based on a contemporary uk population, with comparison to existing risk models. In: Heart. BCS Annual Conference, 05-07 Jun 2017, Manchester, UK. BMJ Publishing Group , A64-A66.